Sustainability continues to steer pharmaceutical packaging market
By Catherine Eckford (European Pharmaceutical Review)
Life sciences response to 2024 Autumn Budget
By Catherine Eckford (European Pharmaceutical Review)
Standout breast cancer trial outcomes for Roche small molecule therapy
By Catherine Eckford (European Pharmaceutical Review)
AbbVie agrees $1.4 billion Alzheimer’s acquisition
By Catherine Eckford (European Pharmaceutical Review)
Life sciences response to 2024 Autumn Budget
By Catherine Eckford (European Pharmaceutical Review)
Developing donanemab – balancing cost versus benefit
By Catherine Eckford (European Pharmaceutical Review)
Future of oral small molecule drugs – addressing potential in…
By Andreas Muehler (Immunic Therapeutics), Daniel Vitt (Immunic Therapeutics)